Alkaloid Synthetic Pathway: Noscapine, a nonaddictive alkaloid found in the opium poppy, can be used as a cough suppressant and a tubulin-binding antitumor agent. Winzer et al. (p. 1704 , published online 31 May; see the Perspective by DellaPenna and O'Connor ) found that a cluster of 10 genes were key to the production of noscapine. Poppies homozygous for this gene cluster produced high levels of noscapine, heterozygous poppies produced low levels of noscapine, and those poppies lacking the gene cluster produced no noscapine. Silencing individual genes in turn and analyzing the accumulation of intermediate metabolites allowed the biosynthetic pathway of noscapine to be elucidated.

Poppy genome reveals evolution of opiates: The opium poppy has been a source of painkillers since Neolithic times. Attendant risks of addiction threaten many today. Guo et al. now deliver a draft of the opium poppy genome, which encompasses 2.72 gigabases assembled into 11 chromosomes and predicts more than 50,000 protein-coding genes. A particularly complex gene cluster contains many critical enzymes in the metabolic pathway that generates the alkaloid drugs noscapine and morphinan. Science , this issue p. 343

Substrate channeling in morphine biosynthesis: Poppies are still the most economically viable source of the excellent painkiller morphine. Winzer et al. have now identified a key enzyme in the poppy's biosynthetic pathway for morphine. The enzyme turns out to be an unusual protein that contains both cytochrome P-450 and oxidoreductase modules. Together these modules process two subsequent steps in the biosynthetic pathway. The identification of this enzyme may enable alternate routes for morphine biosynthesis that are less dependent on poppy cultivation. Science , this issue p. 309